share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Feb 8 21:05

Gainers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 122.5% to $4.05 during Thursday's pre-market session. The company's market cap stands at $2.2 million.
  • Titan Pharma (NASDAQ:TTNP) stock moved upwards by 27.59% to $8.0. The company's market cap stands at $6.0 million.
  • Trxade Health (NASDAQ:MEDS) shares rose 18.73% to $5.32. The company's market cap stands at $6.4 million.
  • Elicio Therapeutics (NASDAQ:ELTX) shares moved upwards by 17.8% to $3.97. The company's market cap stands at $38.1 million.
  • Nutex Health (NASDAQ:NUTX) stock increased by 17.63% to $0.13. The market value of their outstanding shares is at $97.9 million.
  • Mineralys Therapeutics (NASDAQ:MLYS) shares rose 16.51% to $14.53. The market value of their outstanding shares is at $597.2 million.

Losers

  • Jin Medical International (NASDAQ:ZJYL) shares decreased by 93.9% to $13.26 during Thursday's pre-market session. The market value of their outstanding shares is at $103.7 million.
  • Tenax Therapeutics (NASDAQ:TENX) shares fell 52.39% to $6.79. The company's market cap stands at $2.3 million.
  • InVivo Therapeutics Hldg (NASDAQ:NVIV) stock declined by 17.61% to $0.53. The company's market cap stands at $1.6 million.
  • HOOKIPA Pharma (NASDAQ:HOOK) shares declined by 13.6% to $0.58. The market value of their outstanding shares is at $57.6 million.
  • ThermoGenesis Holdings (NASDAQ:THMO) shares fell 13.1% to $0.73. The company's market cap stands at $2.2 million.
  • Exicure (NASDAQ:XCUR) stock declined by 13.02% to $0.59. The company's market cap stands at $5.1 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment